Cao Jie, Yuan Jianqing, Liu Nanhai, Huang Kai, Guo Mingwei
Department of Neurology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Front Pharmacol. 2025 May 13;16:1577809. doi: 10.3389/fphar.2025.1577809. eCollection 2025.
Microglia, the resident immune cells of the central nervous system (CNS), are highly dynamic and play critical roles in maintaining CNS homeostasis. Under normal conditions, microglia continuously monitor their environment, clear cellular debris, and regulate homeostasis. In response to disease or injury, however, they undergo rapid morphological and functional changes, often adopting an amoeboid shape that facilitates phagocytosis of abnormal cells, pathogens, and external antigens. Microglia also proliferate in areas of injury or pathology, contributing to immune responses and tissue remodeling. Recently, pharmacological approaches targeting microglial depletion and repopulation have gained attention as a means to reset or modulate microglial function. Techniques such as CSF1R inhibition enable transient depletion of microglia, followed by rapid repopulation, potentially restoring homeostatic functions and mitigating chronic inflammation. This review explores the current understanding of microglial dynamics and highlights emerging therapeutic applications of microglial depletion and repopulation within the CNS.
小胶质细胞是中枢神经系统(CNS)中的常驻免疫细胞,具有高度的动态性,在维持中枢神经系统内环境稳定中发挥着关键作用。在正常情况下,小胶质细胞持续监测其周围环境,清除细胞碎片,并调节内环境稳定。然而,在疾病或损伤的情况下,它们会经历快速的形态和功能变化,通常呈现出变形虫状,便于吞噬异常细胞、病原体和外部抗原。小胶质细胞还会在损伤或病理区域增殖,参与免疫反应和组织重塑。最近,针对小胶质细胞耗竭和再填充的药理学方法作为一种重置或调节小胶质细胞功能的手段而受到关注。诸如抑制集落刺激因子1受体(CSF1R)等技术能够使小胶质细胞短暂耗竭,随后快速再填充,有可能恢复内环境稳定功能并减轻慢性炎症。本综述探讨了目前对小胶质细胞动态变化的理解,并强调了中枢神经系统内小胶质细胞耗竭和再填充的新兴治疗应用。
Front Pharmacol. 2025-5-13
Cell Mol Neurobiol. 2023-8
J Neuroinflammation. 2020-1-18
Cell Death Dis. 2020-10-23
Front Cell Neurosci. 2024-2-15
Brain Behav Immun Health. 2020-3-6
J Neuroinflammation. 2024-4-3
Signal Transduct Target Ther. 2023-9-22
Front Cell Neurosci. 2022-11-4
Front Immunol. 2022
Front Cell Neurosci. 2022-2-7